Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A2A/2B receptors in tolerogenic dendritic cells

[1]  Gang Liu,et al.  Regulatory Fibroblast‐Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid Arthritis , 2022, Advanced science.

[2]  Yu Zhou,et al.  A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal , 2022, Science advances.

[3]  Hao Li,et al.  Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats , 2021, Acta pharmaceutica Sinica. B.

[4]  Yu Zhou,et al.  Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccine , 2021, Therapeutic advances in medical oncology.

[5]  Peng Liu,et al.  Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization. , 2020, Biomaterials.

[6]  G. Firestein,et al.  Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes , 2020, Nature Reviews Rheumatology.

[7]  C. Custódio,et al.  Human Platelet Lysates‐Based Hydrogels: A Novel Personalized 3D Platform for Spheroid Invasion Assessment , 2020, Advanced science.

[8]  Luis M. Rodríguez-Lorenzo,et al.  Alginate hydrogels for bone tissue engineering, from injectables to bioprinting: A review. , 2020, Carbohydrate polymers.

[9]  Bingjie Zhang,et al.  Tolerogenic Dendritic Cells Generated by BAFF Silencing Ameliorate Collagen-Induced Arthritis by Modulating the Th17/Regulatory T Cell Balance , 2019, The Journal of Immunology.

[10]  Caglar Cekic,et al.  Adenosine Receptor Signaling Targets Both PKA and Epac Pathways to Polarize Dendritic Cells to a Suppressive Phenotype , 2019, The Journal of Immunology.

[11]  S. Zheng,et al.  Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adenosine signal pathway in autoimmune arthritis , 2019, EBioMedicine.

[12]  Tae Wook Lee,et al.  Recent advances in stem cell therapeutics and tissue engineering strategies , 2018, Biomaterials Research.

[13]  Cinthia Silva-Vilches,et al.  ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity , 2018, Front. Immunol..

[14]  D. Kong,et al.  Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity. , 2018, Nano letters.

[15]  Wenmiao Shu,et al.  3D bioactive composite scaffolds for bone tissue engineering , 2017, Bioactive materials.

[16]  Yingjie Zhang,et al.  IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway. , 2017, Kidney international.

[17]  Boguang Yang,et al.  Injectable Fullerenol/Alginate Hydrogel for Suppression of Oxidative Stress Damage in Brown Adipose-Derived Stem Cells and Cardiac Repair. , 2017, ACS nano.

[18]  C. De Bari,et al.  Mesenchymal stem cells for the management of rheumatoid arthritis: immune modulation, repair or both? , 2017, Current opinion in rheumatology.

[19]  J. Linden,et al.  Purinergic regulation of the immune system , 2016, Nature Reviews Immunology.

[20]  Y. Li,et al.  Methyl salicylate lactoside inhibits inflammatory response of fibroblast‐like synoviocytes and joint destruction in collagen‐induced arthritis in mice , 2014, British journal of pharmacology.

[21]  J. Karp,et al.  Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.

[22]  Simon A. Jones,et al.  The problem of choice: current biologic agents and future prospects in RA , 2013, Nature Reviews Rheumatology.

[23]  Georg Schett,et al.  Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment , 2012, Nature Reviews Rheumatology.

[24]  E. Yannaki,et al.  Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis , 2012, Annals of the rheumatic diseases.

[25]  D. Mougiakakos,et al.  Multipotent mesenchymal stromal cells and the innate immune system , 2012, Nature Reviews Immunology.

[26]  Jeffrey M Karp,et al.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. , 2012, Cell stem cell.

[27]  Georg Schett,et al.  The pathogenesis of rheumatoid arthritis. , 2011, The New England journal of medicine.

[28]  J. Jacobs,et al.  Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis , 2010, Nature Reviews Rheumatology.

[29]  Nikolay Bazhanov,et al.  Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties , 2010, Proceedings of the National Academy of Sciences.

[30]  Yi Zhang,et al.  A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone , 2010, Nature Protocols.

[31]  S. Shi,et al.  Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis1 , 2009, The Journal of Immunology.

[32]  J. Greenberg,et al.  Dendritic cells as targets for therapy in rheumatoid arthritis , 2009, Nature Reviews Rheumatology.

[33]  D. Littman,et al.  Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.

[34]  Lars Klareskog,et al.  Rheumatoid arthritis , 2009, The Lancet.

[35]  X. Hua,et al.  Modulation of murine dendritic cell function by adenine nucleotides and adenosine: Involvement of the A2B receptor , 2008, European journal of immunology.

[36]  C. Hawrylowicz,et al.  Strategies for use of IL‐10 or its antagonists in human disease , 2008, Immunological reviews.

[37]  Giuseppe Leone,et al.  Tolerogenic dendritic cells: cytokine modulation comes of age. , 2006, Blood.

[38]  C. Hawrylowicz,et al.  Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma , 2005, Nature Reviews Immunology.

[39]  Courtney M. Lappas,et al.  A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells1 , 2005, The Journal of Immunology.

[40]  M. Huber,et al.  Adenosine and cAMP are potent inhibitors of the NF‐κB pathway downstream of immunoreceptors , 2005 .

[41]  Wei Zhang,et al.  Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. , 2004, Stem cells and development.

[42]  M. Idzko,et al.  Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. , 2003, Blood.

[43]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[44]  Ralph Weissleder,et al.  Arthritis critically dependent on innate immune system players. , 2002, Immunity.

[45]  F. Bach,et al.  Identification and Characterization of CD39/Vascular ATP Diphosphohydrolase* , 1996, The Journal of Biological Chemistry.

[46]  H Zimmermann,et al.  5'-Nucleotidase: molecular structure and functional aspects. , 1992, The Biochemical journal.

[47]  Chen Li,et al.  Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine. , 2017, Biomaterials.